Preladenant is a selective adenosine A2A receptor antagonist that has been investigated in clinical trials for the treatment of neurological conditions such as Parkinson’s disease and other movement disorders.… Read more
Preladenant is a selective adenosine A2A receptor antagonist that has been investigated in clinical trials for the treatment of neurological conditions such as Parkinson’s disease and other movement disorders. As part of rigorous analytical testing and quality control protocols, researchers rely on high-quality reference standards of the drug substance to ensure accurate identification and quantification. The category encompasses a range of related compounds, including pharmacopeial and non-pharmacopeial impurities, which are critical for comprehensive impurity profiling and method validation. Additionally, the availability of stable isotope-labelled compounds, such as Preladenant-d3, provides essential internal standards for mass spectrometry-based assays. By utilizing these precise analytical tools, pharmaceutical laboratories can effectively monitor drug stability, assess degradation pathways, and verify the purity of the active pharmaceutical ingredient throughout the drug development and manufacturing lifecycle.